Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

de Moraes FCA, de Castro Ribeiro CHD, Pessoa FDDL, Chaves JR, et al. Pathologic response rates in HER2-low versus HER2-zero early breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis. Breast Cancer Res 2025;27:39.
PMID: 40089780


Privacy Policy